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Background: Counseling in combination with pedometer use has proven to be effective in increasing physical
activity and improving health outcomes. We investigated the cost-effectiveness of this intervention targeted at one
million insufficiently active adults who visit their general practitioner in the Netherlands.
Methods: We used the RIVM chronic disease model to estimate the long-term effects of increased physical activity
on the future health care costs and quality adjusted life years (QALY) gained, from a health care perspective.
Results: The intervention resulted in almost 6000 people shifting to more favorable physical-activity levels, and in
5100 life years and 6100 QALYs gained, at an additional total cost of EUR 67.6 million. The incremental
cost-effectiveness ratio (ICER) was EUR 13,200 per life year gained and EUR 11,100 per QALY gained. The
intervention has a probability of 0.66 to be cost-effective if a QALY gained is valued at the Dutch informal threshold
for cost-effectiveness of preventive intervention of EUR 20,000. A sensitivity analysis showed substantial uncertainty
of ICER values.
Conclusion: Counseling in combination with pedometer use aiming to increase physical activity may be a
cost-effective intervention. However, the intervention only yields relatively small health benefits in the Netherlands.
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Lack of physical activity increases the risk of numerous
adverse health conditions, including coronary artery dis-
ease, hypertension, stroke, insulin sensitivity, osteopor-
osis, and cancer [1]. In the Netherlands, it has been
estimated that about 6% of total mortality can be attrib-
uted to physical inactivity [2]. In 2007, about 44% of the
Dutch population aged 12 or above did not meet the
recommendation to accumulate at least 30 minutes of
moderate-intensity physical activity on at least five days
of the week, and were classified as physically inactive
(17%) or insufficiently active (27%) [3]. Therefore,* Correspondence: eelco.over@rivm.nl
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reproduction in any medium, provided the orincreasing physical activity has the potential to reduce
the burden of disease in the Netherlands considerably.
Recently, pedometers have become a popular tool for
motivating people to engage in physical activity [4,5].
Pedometers are small, relatively inexpensive, devices
worn at the hip to count the number of steps walked per
day. Together with a calendar, diary, or daily log to keep
record of and reflect on the amount of physical activity,
the pedometer can be used to effectively increase daily
physical activity [5]. A meta-analysis by Bravata et al. [4]
of eight randomized controlled trials showed an average
increase of 2491 (95% C.I. 1098 – 3885) steps per day
among insufficiently-active outpatient adults and seden-
tary healthy adults randomly assigned to pedometer use
for a mean period of 18 weeks (range: 3–104 weeks).
These pedometer interventions, of which about two
thirds included additional physical activity counseling,
improved the patients’ risk factor profiles: on average,d. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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pressure by 3.8 mmHg and diastolic blood pressure by
0.3 mmHg.
Although pedometer use has been shown to be effective
in increasing physical activity and improving health out-
comes, little is known about its cost-effectiveness. To our
knowledge, only two cost-effectiveness studies were pub-
lished [6,7]. Using a simulation model, Cobiac and collea-
gues investigated the cost-effectiveness of pedometer use
in the Australian population from a health care perspec-
tive. They reported that the use of pedometers in the
Australian population would be dominant, i.e. it would be
successful in averting disability adjusted life years and less
costly compared to standard care. In this cost-
effectiveness study, the pedometer intervention was ap-
plied through a community program, targeted at everyone
aged 15 and over. Cobiac et al. assumed that 12.5% of the
target population would start using a pedometer. They did
not state how the pedometers would be distributed, and
the direct intervention costs were calculated as a weighted
average from each of the eight randomized controlled
trials analyzed by Bravata et al. [4]. De Smedt and collea-
gues also reported that the Belgian community-based ped-
ometer intervention “10,000 Steps Ghent” would be
dominant. In their state-transition Markov model there
was a direct link between increased walking and reduced
risks of diabetes and cardiovascular and oncological life
events. They modeled continuous implementation of the
pedometer intervention.
In the present study, we used mathematical modeling
to perform a cost-effectiveness analysis (CEA) of coun-
seling in combination with pedometers in a primary care
setting. The outcome of this CEA is expressed in the in-
cremental cost-effectiveness ratio (ICER) - the ratio of
incremental costs to incremental effects of the interven-
tion - expressed in 2009 euros per quality adjusted life
year (QALY) [8].
Methods
Two scenarios
We compared the scenario in which general practi-
tioners (GPs) offer their patients that have been identi-
fied as being insufficiently active to use a pedometer
(pedometer scenario) to the scenario of current practice.
In the current practice scenario, no additional actions
are taken with respect to the patients’ physical activity,
assuming that their physical activity will only change be-
cause of aging. Table 1 shows the course of the pedom-
eter scenario and the number of participants in each
stage of the intervention. In 2008, the total Dutch popu-
lation aged 20–65 years accounted for about 10 million
people [9] and 7.27 million of them visited the GP at
least once according to Statistics Netherlands [10]. We
assumed that the percentage of GPs participating in thepedometer intervention would be equal to the percent-
age that opportunistically offers a minimal smoking-
cessation intervention in the Netherlands, namely
35%-40% [11]. We assumed that this percentage would
be equal to the percentage of the Dutch population hav-
ing access to the pedometer intervention. Patients visiting a
participating GP fill in a short physical activity question-
naire: the SQUASH, introduced by Wendel-Vos et al. [12].
Wendel-Vos et al. showed that 83% of the people that
were offered a SQUASH, actually filled it in. The GP then
scores the SQUASH, informs the patients about their
physical-activity level, and offers a pedometer to those
patients who are not sufficiently active, which is approxi-
mately 44% [3]. The patients further have to attend three
follow-up sessions with the GP’s assistant to complete the
pedometer intervention. No data is currently available as
to how many patients would be willing to accept a pedom-
eter and how many of those would participate in the
follow-up sessions. Therefore, we assumed these last two
parameters to be 50%, and applied large confidence inter-
vals (CI) around them in the sensitivity analysis (see
below). The pedometer scenario is assumed to increase
the physical-activity levels of those patients completing
the pedometer intervention by 2491 steps per day after
one year, which is the average increase in steps found by
Bravata et al. [4].
The RIVM chronic disease model
We used the RIVM Chronic Disease Model (CDM), a
Markov-type state-transition model [13-15], to calculate
the effects of the pedometer scenario compared to the
current practice scenario, in terms of QALYs. The
QALYs were calculated by attaching appropriate utility
weights to each possible health state in the model. The
CDM is a computer model that can simulate the inci-
dence, prevalence, and mortality of diabetes, myocardial
infarction, stroke, and colorectal and breast cancer be-
cause of physical inactivity among the Dutch population.
The incidence and mortality of these diseases also de-
pend on the presence of other diseases via relative risks.
All data in the model are age and sex specific. For a fully
detailed description of the RIVM CDM, see Hoogenveen
et al. [14]. We discounted all future effects at 1.5%, as
recommended in the Dutch guidelines for pharmacoeco-
nomic research [16].
The scenario input of the CDM is a change in one or
more risk factor distributions. The risk factor “physical
activity” in the CDM consists of three discrete levels,
analogous to the Dutch physical-activity guideline [17]
(see below). We calculated the shift to more favorable
levels of physical activity, due to additional steps in the
pedometer scenario, on the basis of data from the annual
General Public Health and Lifestyle Survey (Dutch acro-
nym: POLS) from 2001 to 2007, conducted by Statistics
Table 1 Numbers of persons in successive stages of the pedometer scenario, and associated costs
Number of
persons
Calculation Type of cost Cost per
person
Total cost
Dutch population aged 20–65 years visiting GP 7,270,000
Visiting participating GP 2,726,000 7,270,000*0.375 Approaching patients, by
GP assistant (1 min)
0.66 1,799,160
Screened with the SQUASH questionnaire 2,263,000 2,726,000*0.83 Checking physical-activity
level, by GP (3 min)
6.66 15,071,580
Target population (those not norm active) 997,900 2,263,000*0.441 Counseling, by GP (10 min) 22.20 22,153,380
Receiving a pedometer 498,900 997,900*0.50 Pedometer with
electronic diary
19.95 9,953,055
Participating in follow-up sessions 249,500 498,900*0.50 Three follow-up sessions, by
GP assistant (10 min each)
19.80 4,940,100
Not changing physical-activity level: 243,600 Based on POLS
data, and estimation
of long-term effect
(see Methods
section)
Inactive adults becoming semi-active: 1,300
Inactive adults becoming norm active: 3,500
Insufficiently active adults becoming norm active: 1,100
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ference between two distributions over the physical-
activity levels: 1) the distribution of the entire POLS data
set, and 2) the distribution of a subgroup of people in
the POLS data set as walking (in commuter traffic or at
one’s leisure) an average 23 minutes more than the aver-
age of the entire POLS data set. With an average step
pace of 106 steps per minute (see also [5,6]), 2491 cor-
respond to 23 minutes of walking. The three levels of
the Dutch physical activity guideline [17] are: 1) inactive
(less than 30 minutes of at least moderately intense
physical activity at all days of the week), 2) insufficiently
active (30 minutes or more of at least moderately intense
physical activity at one to four days of the week), and 3)
norm active (30 minutes or more of at least moderately
intense physical activity at five or more days of the
week). We calculated the shift of the physical-activity
levels separately for people younger and older than
55 years because “moderately intense” is defined differ-
ently for these two age groups [17].
Because the RIVM CDM input needs long-term effects
as input, and because it is unknown how long physical-
activity effects maintain, we used the estimation method
of Jacobs-van der Bruggen et al. [18] to calculate the
fraction of the effect that is maintained after 18 weeks.
They estimated that long-term physical-activity effects
for people with a life expectancy of almost 15 years
would be 55% of the effect after one year. Taking into
account that the life expectancy of our cohort of adults
was almost 40 years and that the effect of 2491 steps oc-
curred after 18 weeks, we estimated a long-term pedom-
eter effect of approximately 25% of the additional 2491
steps, namely 623 steps, which corresponds to 6 minutes
of walking. We performed a sensitivity analysis for thelong-term effect with 12.5% and 50% of 2491 steps, cor-
responding to 3 and 12 minutes of additional walking
per day, respectively.
The RIVM CDM also provided estimates for the costs
of healthcare, including those in years lived longer [19].
As recommended in the Dutch guidelines for pharma-
coeconomic research [16], we discounted all future costs
at the annual percentage of 4.0%, and calculated the
costs of the intervention using a so-called bottom-up
method. Table 1 shows the unit costs and total interven-
tion costs used. We calculated all costs in 2009 euros.
We used the probabilistic sensitivity analysis (PSA) to
account for uncertainty in the input parameters of the
model (see Table 2). We ran the model 100,000 times,
varying all parameters simultaneously. For the incidence,
prevalence, and mortality rates of each disease [20], we
had coupled sets of random draws because they are
dependent parameters.
Results
The pedometer scenario resulted in 4,600 life years or
5,500 QALYs gained compared to the current practice
scenario. Figure 1 displays the amount of life years and
QALYs gained as a function of future time. The inter-
vention costs amounted to EUR 54.1 million, the health-
care costs (including costs in life years gained)
amounted to EUR 7.1 million, making the total costs
EUR 61.2 million. This resulted in an ICER of EUR
11,100 per QALY, and EUR 13,200 per life year.
The sensitivity analysis for the long-term effect of add-
itional walking per day showed an ICER of EUR 22,300
per QALY, and EUR 26,400 per life year for three extra
minutes of walking. For 12 additional minutes of walk-
ing, the ICER was EUR 5,200 per QALY, and EUR 6,100
Table 2 Uncertain model parameters and their properties
Distribution Mean 95% CI Reference
Fraction of participating GPs beta 0.375 0.056–0.789 [11]
Fraction filling in SQUASH beta 0.83 0.54–0.99 [12]
Costs for scoring SQUASH 2.22 * (1+ 4*beta) 6.66 3.37–9.95 Expert opinion. Minimum
one minute (digital scoring) to
maximum five minutes
(manual scoring, multiple sports)
Fraction accepting pedometer,
and fraction completing
follow-up sessions
beta 0.50 0.13–0.87
Additional steps per day normal 2491 1098–3885 [4]
Fraction of the effect sustained
in the long term
beta 0.25 0.08–0.47 [18]
Incidence, prevalence, and mortality
rates of each disease
Poisson and binomial [20]
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effects plane for the pedometer scenario compared to
the current practice scenario, following from the PSA.
Each dot represents a model run, with random values
for the parameters mentioned in Table 2. The costs
included those in life years gained, and the effects were
expressed in QALYs. Table 3 shows the mean incremen-
tal life years and QALYs gained, health care costs in-
curred and the resulting ICER for the pedometer
scenario compared to the current practice scenario.
Figure 3 displays the cost-effectiveness acceptability
curve for the pedometer scenario. Counseling in com-
bination with pedometer use had a probability of 0.66 to
be cost-effective when the threshold is EUR 20,000 per
QALY gained. Since the Dutch informal threshold for
cost-effectiveness of preventive interventions is EUR
20,000 per QALY, the pedometer scenario appeared to
be cost-effective.0 20 40 60 80 100
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Figure 1 Future effects of the pedometer scenario. Life years
(dashed line) and QALYs (solid line) gained in the pedometer
scenario compared to the current practice scenario.Discussion
In this study, we have made some assumptions that need
to be confirmed by further research. We used meta-
analysis based results of the effect of pedometer use on
the number of additional steps per day. However, the po-
tential effect of pedometer use in the Dutch population
is debatable. For the pedometer scenario, we used an
additional 2491 steps per day after one year [4], but
walking is already a substantial part of the daily physical
activity pattern in the Netherlands [21]. It therefore
remains to be seen if pedometer use in the Netherlands
would indeed result in an additional 2491 steps per day.
This may have led to an underestimation of the ICER.
On top of that, the randomized controlled trials in Bra-
vata et al. were mainly targeted at sedentary adults. The
cohort of adults in our study is mostly not sedentary,
and thus we may have overestimated the effects, also
leading to an underestimation of the ICER. On the other
hand, the additional 2491 steps found by Bravata et al.
was a pooled effect of interventions with and without
counseling, whereas our pedometer intervention always
included counseling. This could mean that we underesti-
mated the effects, and overestimated the ICER. We also
had to make an assumption about the long-term effect
of pedometers, which we estimated to be 25% of the ef-
fect after one year, namely 623 steps or 6 minutes per
day. The accuracy of this estimation is unknown. If the
long-term effect would amount to only three or less
minutes of walking per day, the pedometer intervention
would not be cost-effective.
A limitation of this study is that physical activity in the
RIVM CDM is modeled via discrete classes: inactive, in-
sufficiently active, and sufficiently active. Obviously, the
real distribution of physical activity over the Dutch
population is continuous, and even a single step per day
more may have a (may it be minuscule) positive effect
on health outcomes. Using discrete classes for physical
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Figure 2 Incremental costs and effects plane. Costs versus effects for 100,000 simulations of the pedometer scenario compared to the current
practice scenario (including health care costs in life years gained).
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outcomes.
In this study, we have chosen the health care perspec-
tive, focusing on health gains and health care costs but
ignoring broader societal costs and consequences (higher
labor productivity, less absenteeism, less environmental
pollution, non-medical consumption in life years gained)
of an increase in physical activity that fall outside the
scope of the health care budget. This may have led to an
overestimation of the ICER.
Comparing our results with the results of two previous
economic evaluations, both Cobiac et al. [6] and De
Smedt et al. [7] found the cost-effectiveness of their ped-
ometer intervention to be dominant, i.e. health gain can
be achieved while saving costs compared to current prac-
tice. A possible explanation for the more favorable result
of Cobiac et al. [6] may be that the average proportion of
inactive persons is much larger in the Australian than in
the Dutch population (about 35% vs. 17%), which implies
a higher possible health gain. De Smedt et al. [7] used
much lower costs per person compared to our program
costs: The total program costs per person accumulatedTable 3 Estimates of total incremental costs and effects
Health
Life years gained
QALYs gained
Intervention costs (million EUR)
Future health care costs difference (million EUR) Exclude
Include
Total costs difference (million EUR) Exclude
Include
Euros per life year gained (EUR) Exclude
Include
Euros per QALY gained (EUR) Exclude
Include
Average costs and effects (95% CI) for the pedometer scenario compared to the cu
and QALYs gained) discounted at 1.5% per year.to EUR 3.51 in the first year and EUR 0.23 in the second
until fifth year. This is probably the main reason that
their ICER was more favorable. Another difference be-
tween our and their study is that 65% of their target
population group consisted of highly educated people.
As prevention interventions are often more effective for
high SES than low SES [22,23], the “10,000 Steps Ghent”
program may have been more effective and more cost-
effective than our pedometer intervention.
The cost-effectiveness of the pedometer intervention in
the Netherlands in this study is less favorable than the
cost-effectiveness of other types of physical activity inter-
ventions: an internet-based intervention program, a GP
physical activity prescription program and a program to
encourage more active transport all have a high probabil-
ity of being cost-effective [6], and brief interventions in
primary care [24], exercise referral [24], and mass media-
based community campaign [6] have found to be even
dominant. This difference is probably not due to the na-
ture of the intervention, but rather because 56% of the
Dutch population aged 20–65 already satisfies the Dutch
guidelines for the healthiest level of physical activity.care costs in life years gained
4,900 (200 – 21,700)
5,800 (200 – 25,600)
54.1 (7.3 – 124.8)
d −16.5 (−72.5 – -0.7)
d 7.8 (0.3 – 34.7)
d 37.6 (0.2 – 96.6)
d 61.9 (8.1 – 149.4)
d 7,600
d 12,500
d 6,500
d 10,600
rrent practice scenario. Costs discounted at 4.0% per year, effects (life years
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Figure 3 Cost-effectiveness acceptability curve. Probability of the
pedometer scenario to be cost-effective compared to the current
practice scenario as a function of cost-effectiveness threshold.
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In summary, counseling in combination with pedometer
use in order to increase physical activity appeared to be
cost-effective in the Netherlands From a health care per-
spective. The resulting ICER was EUR 11,100 per QALY
gained, which is below the Dutch informal threshold of
EUR 20,000 per QALY gained. The PSA showed that the
pedometer scenario had a probability of 0.66 to be cost-
effective at this threshold.
However, since the intervention only yields relatively
small health benefits in the Netherlands, it may be more
worthwhile to allocate scarce resources to more cost-
effective physical-activity interventions. Furthermore,
since there is a lack of evidence regarding the extent to
which pedometer users adhere to their increased activity
levels, the uncertainty of the ICER is substantial: The
sensitivity analysis showed a highly skewed distribution
of ICERs, some of them even larger than a million Euros
per QALY. Therefore, some caution is recommended
with respect to the cost-effective nature of the pedom-
eter intervention.
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